Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Selina K. Wong"'
Autor:
Bonnie Leung, Aria Shokoohi, Zamzam Al-Hashami, Sara Moore, Alexandra Pender, Selina K. Wong, Ying Wang, Jonn Wu, Cheryl Ho
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Over the past decade, there has been increasing availability of novel therapeutics with improved tolerability and efficacy for advanced non-small cell lung cancer (NSCLC). The study goals were: to compare the uptake of systemic th
Externí odkaz:
https://doaj.org/article/959f23cddbbe44d1808c0e562adf61bb
Autor:
Aria Shokoohi, Zamzam Al‐Hashami, Sara Moore, Alexandra Pender, Selina K. Wong, Ying Wang, Bonnie Leung, Jonn Wu, Cheryl Ho
Publikováno v:
Cancer Medicine, Vol 11, Iss 1, Pp 86-93 (2022)
Abstract The evolution of diagnosis and treatment of advanced nonsmall‐cell lung cancer (NSCLC) has led to increasing the use of targeted therapy and immune checkpoint inhibitors. The study goal was to assess the effect of molecular testing and the
Externí odkaz:
https://doaj.org/article/70deca79bca340efbf913f9b0cbfff99
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4748-4755 (2021)
Background: Despite successes in the development of innovative anticancer therapies, the fiscal and capacity restraints of the Canadian public healthcare system result in challenges with drug access. A meaningful proportion of systemic therapies ulti
Externí odkaz:
https://doaj.org/article/bde187c330654f0280b2b750608725b6
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Advances in curative treatment for breast, colorectal, NSCLC and prostate cancer have led to improvements in cancer survival. Cancer treatment and recovery time can vary depending on the recommended modalities and intensity of the
Externí odkaz:
https://doaj.org/article/67e306bb1cc34b6fb2ee4a0f21155161
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The addition of immune checkpoint inhibitors (ICIs) to the therapeutic armamentarium for solid malignancies has resulted in unprecedented improvements in patient outcomes in many cancers. The landscape of ICIs continues to evolve with novel approache
Externí odkaz:
https://doaj.org/article/07c9e054d32446cb97d320077b60b483
Autor:
Selina K. Wong, Quincy S.C. Chu, Jennifer L. Spratlin, Randeep Sangha, Alexander J.B. McEwan, Donald W. Morrish, Diane Arndt, Gwen Sergenson, Adriaan Cleton, Funan Huang, Michael B. Sawyer
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 791-795 (2019)
Thyroid cancer is the most common type of endocrine malignancy. Cornerstones of thyroid cancer treatment include surgery, radioactive iodine ablation, and thyroid stimulating hormone suppression. The National Comprehensive Cancer Network guidelines r
Externí odkaz:
https://doaj.org/article/17f84ca3eeef446c9c88b10e69478f3b
Autor:
Selina K. Wong, Wade T. Iams
Publikováno v:
Cancers, Vol 13, Iss 3, p 506 (2021)
After being stagnant for decades, there has finally been a paradigm shift in the treatment of small-cell lung cancer (SCLC) with the emergence and application of immune checkpoint inhibitors (ICIs). Multiple trials of first-line ICI-chemotherapy comb
Externí odkaz:
https://doaj.org/article/c04ae46ac2094d759f30143965e86ee9
Publikováno v:
JCO Oncology Practice. 18:e1716-e1724
PURPOSE: Limited English-proficient (LEP) patients with non–small-cell lung cancer (NSCLC) may receive less palliative care services and more likely to receive aggressive end-of-life (EoL) care. Goals of this retrospective cohort study are to compa
Autor:
Jennifer, G Whisenant, Javier, Baena, Alessio, Cortellini, Li-Ching, Huang, Giuseppe Lo Russo, Luca, Porcu, Selina, K Wong, Christine, M Bestvina, Matthew, D Hellmann, Elisa, Roca, Hira, Rizvi, Isabelle, Monnet, Amel, Boudjemaa, Jacobo, Rogado, Pasello, Giulia, Natasha, B Leighl, Oscar, Arrieta, Avinash, Aujayeb, Ullas, Batra, Ahmed, Y Azzam, Mojca, Unk, Mohammed, A Azab, Ardak, N Zhumagaliyeva, Carlos, Gomez-Martin, Juan, B Blaquier, Erica, Geraedts, Giannis, Mountzios, Gloria, Serrano-Montero, Niels, Reinmuth, Linda, Coate, Melina, Marmarelis, Carolyn, J Presley, Fred, R Hirsch, Pilar, Garrido, Hina, Khan, Alice, Baggi, Celine, Mascaux, Balazs, Halmos, Giovanni, L Ceresoli, Mary, J Fidler, Vieri, Scotti, Anne-Cécile, Métivier, Lionel, Falchero, Enriqueta, Felip, Carlo, Genova, Julien, Mazieres, Umit, Tapan, Julie, Brahmer, Emilio, Bria, Sonam, Puri, Sanjay, Popat, Karen, L Reckamp, Floriana, Morgillo, Ernest, Nadal, Francesca, Mazzoni, Francesco, Agustoni, Jair, Bar, Federica, Grosso, Virginie, Avrillon, Jyoti, D Patel, Fabio, Gomes, Ehab, Ibrahim, Annalisa, Trama, Anna, C Bettini, Fabrice, Barlesi, Anne-Marie, Dingemans, Heather, Wakelee, Solange, Peters, Leora, Horn, Marina Chiara Garassino, Valter, Torri, TERAVOLT study group
Publikováno v:
Journal of Thoracic Oncology, 17(5), 661-674. Elsevier Science
Journal of Thoracic Oncology, 17(5), 661-674. International Association for the Study of Lung Cancer
Journal of Thoracic Oncology, 17(5), 661-674. International Association for the Study of Lung Cancer
Introduction: Patients with thoracic malignancies are at increased risk for mortality from coronavirus disease 2019 (COVID-19), and a large number of intertwined prognostic variables have been identified so far. Methods: Capitalizing data from the Th
Autor:
Selina K. Wong, Steven M. Blum, Xiaopeng Sun, Inês P. Da Silva, Leyre Zubiri, Fei Ye, Kun Bai, Kevin Zhang, Selma Ugurel, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Patricio Serra-Bellver, Eva Muñoz-Couselo, Carolina Ortiz, Julia Lostes, Roberto M. Huertas, Ana Arance, Lisa Pickering, Georgina V. Long, Matteo S. Carlino, Elizabeth I. Buchbinder, Leticia Vázquez-Cortés, Diego Jara-Casas, Iván Márquez-Rodas, Iván R. González-Espinoza, Justin M. Balko, Alexander M. Menzies, Ryan J. Sullivan, Douglas B. Johnson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad18af4887f152790123c41281781b3
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85146852724
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85146852724